Navigation Links
Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
Date:3/3/2008

FREMONT, Calif., March 3 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a high-value molecular diagnostics company, announced today that it has entered into an exclusive license agreement with Stanford University to develop and commercialize a novel biomarker panel used to assess the risk of peripheral artery disease (PAD). Estimated to affect up to 12 million Americans, PAD is a serious condition that often goes undiagnosed. The disease can result in severe complications, including gangrene, amputation, heart attack, stroke and even death.

Under the terms of the agreement, Vermillion is granted exclusive rights to the biomarker panel, and will undertake the development and commercialization of a PAD blood test, which utilizes the multi-marker panel to stratify an individual's risk for developing the disease.

"PAD is underdiagnosed and undertreated. We need new, innovative tools to aid in the diagnosis and management of this life and limb-threatening disease," said John Cooke, M.D., Ph.D., Professor of Medicine at Stanford University whose research has formed the basis of the Vermillion PAD blood test. "Through our successful venture with Vermillion, we are working to develop these essential tools to improve diagnosis, with the intent of expediting treatment and enhancing patient outcomes."

Gail Page, President and CEO of Vermillion, stated, "The license agreement with Stanford demonstrates our commitment to developing high-value molecular diagnostic products that aid in the management of complex diseases, such as PAD. We are confident that our collaboration with this distinguished research institution will continue to result in important clinical advances in the vascular arena."

In collaboration wi
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion Receives NASDAQ Notice of Non-Compliance
2. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
3. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
4. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
5. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
6. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
7. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
8. Stanford researchers hear the sound of quantum drums
9. Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
10. Northeastern University and Mass General Hospital Increase the Accuracy, While Reducing the Diagnosis Time, for Breast Cancer Detection
11. Families of Spinal Muscular Atrophy; University of California, Irvine Stem Cell Scientist; and California Stem Cell Announce Collaboration for Safety Studies for Stem Cell Therapy in Spinal Muscular Atrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" ... announced next steps for its Oral Amphotericin B ... its in vitro work involving samples ... now plans to complete pre clinical studies and ... Phase 1A clinical trial, utilizing approximately $700,000 of ...
(Date:10/20/2014)... , Oct. 20, 2014 Mapp ... experimental ZMapp™ antibody therapeutic to fight the Ebola ... difficult and time-consuming the production of pharmaceuticals can ... research publisher said that while some may be ... this compound, those with industry knowledge are well ...
(Date:10/20/2014)... 2014  GenVec, Inc. (NASDAQ: GNVC ) today ... from its board of directors effective on October 24, 2014.  ... served as its chairman from June 2006 to November 2013.  ... Corporate Governance and Audit Committees of the board.  ... of dedicated service to GenVec, and its stockholders," said ...
(Date:10/19/2014)... The Latin American hardware encryption display market ... with analysis and forecast of revenue. This market was ... to reach $2,366.8 million by 2018, at a CAGR ... the TOC of the Latin American hardware encryption market ... provided. It also provides a glimpse of the segmentation ...
Breaking Biology Technology:iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3Zola P. Horovitz To Retire From GenVec Board 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3
... 15, 2011   Genetics Policy Institute (GPI) announced ... Summit is scheduled for Dec. 3-5, 2012 at ... Beach, Florida. (Logo: http://photos.prnewswire.com/prnh/20111214/DC23304LOGO ) ... at the University of Miami Miller School of Medicine ...
... 2011 ReproCELL, Inc. (CEO: Chikafumi ... worldwide right to commercialize hepatocytes derived from human ... collaborating with the National Institute of Biomedical Innovation ... establish an effective in-vitro drug screening for hepatic ...
... a new way to tune and enhance thermal conductivity ... given material gives engineers a new tool for managing ... number of other powered devices. The finding was made ... professor of mechanical engineering at Vanderbilt University, and published online ...
Cached Biology Technology:West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012 2West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012 3ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012 2New method for enhancing thermal conductivity could cool computer chips, lasers and other devices 2New method for enhancing thermal conductivity could cool computer chips, lasers and other devices 3
(Date:10/15/2014)... Alt will be awarded the 44th Rosenstiel Award for ... his pioneering research exploring the mechanisms of genomic instability ... cells. Alt is the second alumnus to win the ... Prize in 2003. , Alt is the Charles A. ... Harvard Medical School and an investigator at the Howard ...
(Date:10/14/2014)... 2014)—It,s been millions of years since T. rex ... by Ohio University scientists is breathing life back into ... dinosaur snouts. The research has important implications for how ... to enhance the sense of smell and cool their ... Ohio University doctoral student Jason Bourke, lead author of ...
(Date:10/14/2014)... 2014 – High doses of fish oil supplements, rich in ... type of irregular heartbeat in which the heart can beat ... the AFFORD trial led by the Montreal Heart Institute were ... Cardiology on October 7th. , For the trial, 337 ... randomly assigned to 4 grams of fish oil a day ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
... David Schmale prepares plane to collect Fusarium samples. ... autonomous unmanned aerial vehicles (UAVs) to detect airborne ... assistant professor of plant pathology, physiology, and weed ... Sciences, has not only linked agriculture and engineering ...
... college students involves "pulling all-nighters", or a single night ... grade-point averages compared to those who make time for ... presented Wednesday at SLEEP 2007, the 21st Annual Meeting ... in college students is generally inadequate, irregular and of ...
... microbial protein to improve water quality. , But some ... potentially toxic nanoparticles in their own environments, and clean ... same thing on a larger scale. , A ... Lawrence Berkeley National Laboratory found that bacteria from an ...
Cached Biology News:Small, self-controlled planes combine plant pathology and engineering 2Small, self-controlled planes combine plant pathology and engineering 3Microbes at work cleaning up the environment 2